Fulgent Genetics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
172.00
489.00
20,868.00
26,484.00
31,034
Total Accounts Receivable
387.00
2,155.00
4,573.00
4,275.00
6,238
Other Current Assets
151.00
286.00
697.00
2,168.00
2,271
Total Current Assets
710.00
2,930.00
26,138.00
32,927.00
39,543
Net Property, Plant & Equipment
978.00
2,469.00
6,234.00
7,272.00
6,446
Total Investments and Advances
-
-
25,597.00
16,820.00
7,898
Other Assets
432.00
433.00
17.00
39.00
17
Total Assets
2,120.00
5,832.00
58,040.00
58,004.00
54,622
Accounts Payable
165.00
314.00
2,756.00
2,089.00
Income Tax Payable
-
-
124.00
-
Other Current Liabilities
271.00
372.00
436.00
911.00
Total Current Liabilities
436.00
686.00
3,316.00
3,000.00
Deferred Taxes
-
-
189.00
126.00
Other Liabilities
-
-
2.00
6.00
Total Liabilities
436.00
686.00
3,561.00
3,826.00
Common Equity (Total)
10,316.00
40,844.00
54,479.00
54,178.00
Total Shareholders' Equity
1,684.00
5,146.00
54,479.00
54,178.00
Total Equity
1,684.00
5,146.00
54,479.00
54,178.00
Liabilities & Shareholders' Equity
2,120.00
5,832.00
58,040.00
58,004.00
Preferred Stock (Carrying Value)
12,000.00
45,990.00
-
-

About Fulgent Genetics

View Profile
Address
4978 Santa Anita Avenue
Temple City California 91780
United States
Employees -
Website http://www.fulgentgenetics.com
Updated 07/08/2019
Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.